FCA
OM icon

FinTrust Capital Advisors’s Outset Medical OM Stock Holding History

FinTrust Capital Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$14 Sell
1
-40
-98% -$1.19K ﹤0.01% 1370
2024
Q2 		$2.39K Hold
41
– – ﹤0.01% 1172
2024
Q1 		$1.38K Hold
41
– – ﹤0.01% 1138
2023
Q4 		$3.36K Hold
41
– – ﹤0.01% 1024
2023
Q3 		$6.75K Buy
+41
New +$9.68K ﹤0.01% 853

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

FinTrust Capital Advisors's OM Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its Outset Medical (OM) stake by 98% in Q3 2024, selling an estimated $1.19K and leaving 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

FinTrust Capital Advisors first reported a position in OM in Q3 2023 and has held it in 5 quarters since. The position peaked at $6.75K in Q3 2023. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

  • FinTrust Capital Advisors held 1 share of Outset Medical worth $14 as of Q3 2024.
  • FinTrust Capital Advisors sold 40 Outset Medical shares in Q3 2024, an estimated $1.19K.
  • Outset Medical made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1370 holding.
  • FinTrust Capital Advisors first reported a position in Outset Medical in Q3 2023 and has held it in 5 quarters since.
  • FinTrust Capital Advisors's Outset Medical position peaked at $6.75K in Q3 2023.
  • 78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.